ResearcherLeiden University Medical CenterActive in the last 2 years
Bas Boekestijn
Matched on ORCID iD 0000-0003-3682-6560; OpenAlex author ID A5061489414. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper
Papers 9
- Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study. Co-author DOI 10.1093/bjs/znag075↗
- Response to letter of the editor ‘Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions’ Co-author DOI 10.1007/s10689-025-00493-5↗
- Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Co-author DOI 10.1007/s10689-024-00368-1↗
- Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Co-author DOI 10.1007/s10689-024-00394-z↗
- The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1097/mpa.0000000000002335↗
- Small Field-of-View T2-Weighted MRI of the pancreas in a Screening Setting for Hereditary Pancreatic Cancer: Improving Image Quality Through Radial K-Space Sam… Co-author DOI 10.26502/jrci.2809093↗
- Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. First author DOI 10.1053/j.gastro.2023.02.032↗
- Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. First author DOI 10.1200/jco.22.00194↗
- Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillanc… First author DOI 10.1016/j.hpb.2019.02.013↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martin N.J.M. Wasser · 8 shared papers, 2019–2025 · strength 1.84
- Paper Response to letter of the editor ‘Screening for pancreatic cancer in high-risk individuals using MRI: optimization of s… DOI 10.1007/s10689-025-00493-5↗
- Paper Small Field-of-View T2-Weighted MRI of the pancreas in a Screening Setting for Hereditary Pancreatic Cancer: Improving … DOI 10.26502/jrci.2809093↗
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Bert A. Bonsing · 6 shared papers, 2019–2024 · strength 1.04
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Paper Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small les… DOI 10.1007/s10689-024-00394-z↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Monique Esther van Leerdam · 5 shared papers, 2022–2024 · strength 0.94
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Paper Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small les… DOI 10.1007/s10689-024-00394-z↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Hans F. A. Vasen · 5 shared papers, 2019–2024 · strength 0.80
- Paper Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small les… DOI 10.1007/s10689-024-00394-z↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- Jeanin Elise van Hooft · 4 shared papers, 2022–2024 · strength 0.70
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- J. Sven D. Mieog · 4 shared papers, 2022–2024 · strength 0.70
- Paper Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small les… DOI 10.1007/s10689-024-00394-z↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- Derk C.F. Klatte · 4 shared papers, 2022–2024 · strength 0.70
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- Aleksander M. Bogdanski · 3 shared papers, 2024 · strength 0.68
- Paper Small Field-of-View T2-Weighted MRI of the pancreas in a Screening Setting for Hereditary Pancreatic Cancer: Improving … DOI 10.26502/jrci.2809093↗
- Paper Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. DOI 10.1007/s10689-024-00368-1↗
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Thomas P. Potjer · 3 shared papers, 2022–2024 · strength 0.46
- Paper The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. DOI 10.1097/mpa.0000000000002335↗
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Pro… DOI 10.1200/jco.22.00194↗
- Hans Morreau · 2 shared papers, 2022–2023 · strength 0.28
- Paper Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Anal… DOI 10.1053/j.gastro.2023.02.032↗
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Pro… DOI 10.1200/jco.22.00194↗
- Isaura S. Ibrahim · 2 shared papers, 2019–2022 · strength 0.23
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Pro… DOI 10.1200/jco.22.00194↗
- Paper Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a … DOI 10.1016/j.hpb.2019.02.013↗
- Lydia G. van der Geest · 1 shared paper, 2023 · strength 0.15
- Wouter H. de Vos tot Nederveen Cappel · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.